$1.01
0.022.02%
At close: -
$1.03
0.021.98%
After Hours: Apr 14, 6:53 PM EDT
Comments
Loading...
CytoSorbents Analyst Ratings and Price Targets | NASDAQ:CTSO | Benzinga
CytoSorbents Corp has a consensus price target of $5.6 based on the ratings of 5 analysts. The high is $10 issued by D. Boral Capital on April 1, 2025. The low is $1 issued by HC Wainwright & Co. on April 3, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., D. Boral Capital, and D. Boral Capital on April 3, 2025, April 1, 2025, and February 25, 2025, respectively. With an average price target of $7 between HC Wainwright & Co., D. Boral Capital, and D. Boral Capital, there's an implied 579.61% upside for CytoSorbents Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
D. Boral Capital
EF Hutton
B. Riley Securities
B. Riley Securities
1calculated from analyst ratings
Analyst Ratings for CytoSorbents
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/03/2025 | Buy Now | -2.91% | HC Wainwright & Co. | Sean Lee62% | $1 → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 04/01/2025 | Buy Now | 870.87% | D. Boral Capital | Jason Kolbert39% | $10 → $10 | Maintains | Buy | Get Alert |
| 02/25/2025 | Buy Now | 870.87% | D. Boral Capital | Jason Kolbert39% | $10 → $10 | Maintains | Buy | Get Alert |
| 01/13/2025 | Buy Now | 870.87% | D. Boral Capital | Jason Kolbert39% | $10 → $10 | Maintains | Buy | Get Alert |
| 01/03/2025 | Buy Now | 870.87% | D. Boral Capital | Jason Kolbert39% | $10 → $10 | Maintains | Buy | Get Alert |
| 11/12/2024 | Buy Now | 870.87% | D. Boral Capital | Jason Kolbert39% | $10 → $10 | Maintains | Buy | Get Alert |
| 11/11/2024 | Buy Now | -2.91% | HC Wainwright & Co. | Sean Lee62% | $1 → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 11/08/2024 | Buy Now | 870.87% | EF Hutton | Jason Kolbert39% | $10 → $10 | Maintains | Buy | Get Alert |
| 11/04/2024 | Buy Now | 870.87% | EF Hutton | Jason Kolbert39% | $10 → $10 | Maintains | Buy | Get Alert |
| 10/22/2024 | Buy Now | 870.87% | EF Hutton | Jason Kolbert39% | $10 → $10 | Maintains | Buy | Get Alert |
| 10/01/2024 | Buy Now | 870.87% | EF Hutton | Jason Kolbert39% | $10 → $10 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | 870.87% | EF Hutton | Jason Kolbert39% | $10 → $10 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | -2.91% | HC Wainwright & Co. | Sean Lee62% | $1 → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 07/29/2024 | Buy Now | 870.87% | EF Hutton | Jason Kolbert39% | → $10 | Initiates | → Buy | Get Alert |
| 05/15/2024 | Buy Now | 191.26% | B. Riley Securities | Yuan Zhi25% | → $3 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | -2.91% | HC Wainwright & Co. | Sean Lee62% | $1 → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 03/15/2024 | Buy Now | -2.91% | HC Wainwright & Co. | Sean Lee62% | $1 → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 12/29/2023 | Buy Now | -2.91% | HC Wainwright & Co. | Sean Lee62% | $5.5 → $1 | Downgrade | Buy → Neutral | Get Alert |
| 09/07/2023 | Buy Now | 288.35% | B. Riley Securities | Justin Walsh42% | → $4 | Reinstates | Buy → Buy | Get Alert |
| 08/02/2023 | Buy Now | 433.98% | HC Wainwright & Co. | Sean Lee62% | → $5.5 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2023 | Buy Now | 433.98% | HC Wainwright & Co. | Sean Lee62% | → $5.5 | Reiterates | → Buy | Get Alert |
| 03/10/2023 | Buy Now | 433.98% | HC Wainwright & Co. | Sean Lee62% | → $5.5 | Reiterates | → Buy | Get Alert |
| 11/04/2022 | Buy Now | 433.98% | HC Wainwright & Co. | Sean Lee62% | $9 → $5.5 | Maintains | Buy | Get Alert |
| 05/04/2022 | Buy Now | 482.52% | B. Riley Securities | Justin Walsh42% | $7 → $6 | Maintains | Buy | Get Alert |
| 05/04/2022 | Buy Now | 773.79% | HC Wainwright & Co. | Sean Lee62% | $13 → $9 | Maintains | Buy | Get Alert |
FAQ
What is the target price for CytoSorbents (CTSO) stock?
The latest price target for CytoSorbents (NASDAQ:CTSO) was reported by HC Wainwright & Co. on April 3, 2025. The analyst firm set a price target for $1.00 expecting CTSO to fall to within 12 months (a possible -2.91% downside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CytoSorbents (CTSO)?
The latest analyst rating for CytoSorbents (NASDAQ:CTSO) was provided by HC Wainwright & Co., and CytoSorbents reiterated their neutral rating.
When was the last upgrade for CytoSorbents (CTSO)?
There is no last upgrade for CytoSorbents
When was the last downgrade for CytoSorbents (CTSO)?
The last downgrade for CytoSorbents Corp happened on December 29, 2023 when HC Wainwright & Co. changed their price target from $5.5 to $1 for CytoSorbents Corp.
When is the next analyst rating going to be posted or updated for CytoSorbents (CTSO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CytoSorbents, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CytoSorbents was filed on April 3, 2025 so you should expect the next rating to be made available sometime around April 3, 2026.
Is the Analyst Rating CytoSorbents (CTSO) correct?
While ratings are subjective and will change, the latest CytoSorbents (CTSO) rating was a reiterated with a price target of $1.00 to $1.00. The current price CytoSorbents (CTSO) is trading at is $1.03, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.